A2M has been shown to upregulate the tumour suppressor PTEN and inhibit cell proliferation in various cancer cell lines, including melanoma, suggesting a tumour‐inhibitory mechanism that could be therapeutically exploited.59 Here, A2M is linked to melanoma.